Physician profile
Ajit Mathur
NPI 1124049200
$344.59
in general payments reported to CMS, 2019-2025
11 companies · $41.87 in 2025
The $41.87 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.97 · 2020: $28.62 · 2021: $69.66 · 2022: $46.64 · 2023: $59.20 · 2024: $60.63 · 2025: $41.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $59.11 | 2023-2025 | |
| Ironshore Pharmaceuticals INC. | $58.59 | 2019-2023 | Jornay Pm |
| Sanofi Pasteur INC. | $42.41 | 2021-2023 | |
| Cranial Technologies, INC | $37.97 | 2021-2024 | Doc Band |
| Supernus Pharmaceuticals, INC. | $31.23 | 2021-2022 | |
| Biogen, INC. | $31.06 | 2020-2021 | |
| Sobi, INC | $27.38 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $19.27 | 2025 | Koselugo |
| Phadia US INC. | $13.51 | 2024 | Immunocap |
| Corium, LLC | $12.78 | 2024 | Azstarys |
| Merck Sharp & Dohme LLC | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajit Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.